Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Unnotable thanks for posting....are you a shareholder here?

<< Previous

Bullboard Posts

Next >>

Post by HarryCallahan45on Aug 05, 2021 9:03pm

288 Views

Post# 33661719

Unnotable thanks for posting....are you a shareholder here?

Sadly i have a large position that i may begin to unwind for exactly the reasons you have articulated....NO INSIDER OWNERSHIP. None of the usual pumpers here have been able to articulate a reason why that is. If we are about to "upend" cancer treatment...wouldnt those in the know be buying with both hands???? No one can answer....

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?